β-Amyloid (1–42) Levels in Cerebrospinal Fluid and Cerebral Atrophy in Mild Cognitive Impairment and Alzheimer’s Disease

β-Amyloid (1–42) Levels in Cerebrospinal Fluid and Cerebral Atrophy in Mild Cognitive Impairment and Alzheimer’s Disease

Background: Recent studies consistently reported Alzheimer’s disease (AD) and, to a lower extent, mild cognitive impairment (MCI) to be accompanied by reduced cerebrospinal fluid (CSF) levels of β-amyloid. However, how these changes are related to brain morphological alterations is so far only partl...

Full description

Bibliographic Details
Main Authors: Elmar Kaiser, Philipp A. Thomann, Marco Essig, Johannes Schröder
Format: Article
Language:English
Published: Karger Publishers 2011-11-01
Series:Dementia and Geriatric Cognitive Disorders Extra
Subjects:
Aging-associated cognitive decline
Biomarkers
Cerebrospinal fluid
Hippocampus
Mild cognitive impairment
MRI
Voxel-based morphometry
Online Access:http://www.karger.com/Article/FullText/333082

Internet

http://www.karger.com/Article/FullText/333082

Similar Items